Vaccines for tumour prevention
- 1 March 2006
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 6 (3) , 204-216
- https://doi.org/10.1038/nrc1815
Abstract
Despite tremendous progress in basic and epidemiological research, effective prevention of most types of cancer is still lacking. Vaccine use in cancer therapy remains a promising but difficult prospect. However, new mouse models that recapitulate significant features of human cancer progression show that vaccines can keep precancerous lesions under control and might eventually be the spearhead of effective and reliable ways to prevent cancer.Keywords
This publication has 103 references indexed in Scilit:
- Cancer Prevention: A Global PerspectiveJournal of Clinical Oncology, 2005
- Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunizationEuropean Journal of Immunology, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- Combination of a Poxvirus-Based Vaccine with a Cyclooxygenase-2 Inhibitor (Celecoxib) Elicits Antitumor Immunity and Long-Term Survival in CEA.Tg/MIN MiceCancer Research, 2004
- Orthotopic models of cancer for preclinical drug evaluationEuropean Journal Of Cancer, 2004
- Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivityBlood, 2003
- Overview of the main outcomes in breast-cancer prevention trialsThe Lancet, 2003
- Identification of tumour-associated t-cell epitopes for vaccine developmentNature Reviews Cancer, 2002
- p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaInternational Journal of Cancer, 2000
- Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactationOncogene, 1999